Pilot study for the treatment response evaluation in glioblastoma with vessel architectural imaging (VAI)

Pilot study for the treatment response evaluation in glioblastoma with vessel architectural imaging (VAI) - VAI pilot study in glioblastomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46808

Enrollment

Registered

2018-10-31

Start date

2018-07-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain cancer Brain tumour GBM glioblastoma multiforme

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Histological confirmed glioblastoma after standard treatment - New contrast enhancing lesion on follow-up MRI - Written informed consent

Exclusion criteria

Exclusion criteria: - Minors (

Design outcomes

Primary

Measure	Time frame
Primary endpoints are true positive, false positive, true negative, and false negative values of VAI MRI. The reference will be definitive diagnosis according to standard radiological follow-up.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results